-
-
18+Age Range
-
91Locations
-
Recruiting
Recruiting
Connect® Myeloid Disease Registry
The purpose of the Connect® Myeloid disease registry is to provide unique insights into treatment decisions and treatment patterns as they relate to clinical outcomes of patients with myeloid diseases in routine clinical practice. This disease registry will also evaluate molecular and cellular markers that may provide further prognostic classification which may or may not be predictive of therapy and clinical outcomes.
Luspatercept treated cohort (LTC)
Newly diagnosed Acute Myeloid Leukemia (AML)
Newly diagnosed Higher-Risk Myelodysplastic Syndromes (HR-MDS)
Newly diagnosed Idiopathic cytopenia of undetermined significance (ICUS)
Newly diagnosed Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Treated Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Treated Myelofibrosis (MF)